Loading the map…
Financial intermediation not elsewhere classified · London
Smithkline Beecham (Investments)
Smithkline Beecham (Investments) Limited
Private limited company registered in London, classed under “Financial intermediation not elsewhere classified”.
Headline figures
No figures yet.
This company's accounts are on file with Companies House, but we haven't extracted them yet. Once we do, its net assets, cash, reserves and any disclosed profit will appear here.
Timeline
Checked 2026-11-01
- AccountsAudit exemption subsidiary accounts made up to 31 December 2025
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/25
- FilingAudit exemption statement of guarantee by parent company for period ending 31/12/25 (and 15 more like it since 24 October 2001)
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/25
- AccountsAudit exemption subsidiary accounts made up to 31 December 2024
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/24
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/24
- AddressRegister(s) moved to registered office address 79 New Oxford Street London WC1A 1DG
- AddressRegister(s) moved to registered inspection location
- DirectorsDirector's details changed for Mrs Laura Guittard on 11 September 2024
- OwnershipChange of details for Smithkline Beecham Limited as a person with significant control on 11 September 2024
- OwnershipChange of details for Setfirst Limited as a person with significant control on 11 September 2024
27 earlier
- AddressRegistered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024
- AddressRegister inspection address has been changed
- AccountsAudit exemption subsidiary accounts made up to 31 December 2023
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/23
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/23
- AccountsAudit exemption subsidiary accounts made up to 31 December 2022
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/22
- DirectorsDirector's details changed for Glaxo Group Limited on 6 June 2023
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/22
- AccountsAudit exemption subsidiary accounts made up to 31 December 2021
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/21
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/21
- DirectorsAppointment of Mrs Laura Guittard as a director on 11 January 2022
- DirectorsTermination of appointment of Ciara Martha Lynch as a director on 11 January 2022
- AccountsAudit exemption subsidiary accounts made up to 31 December 2020
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/20
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/20
- AccountsAudit exemption subsidiary accounts made up to 31 December 2019
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/19
- DirectorsTermination of appointment of Charalampos Panagiotidis as a director on 2 March 2020
- DirectorsAppointment of Mrs Ciara Martha Lynch as a director on 2 March 2020
- DirectorsTermination of appointment of Adam Walker as a director on 2 March 2020
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/19
- AccountsFull accounts made up to 31 December 2018
- DirectorsAppointment of Mr Charalampos Panagiotidis as a director on 15 February 2019
- AccountsFull accounts made up to 31 December 2017
- AccountsFull accounts made up to 31 December 2016
- Address
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Smithkline Beecham (Investments) do?
Private limited company registered in London, classed under “Financial intermediation not elsewhere classified”.
›How much turnover does Smithkline Beecham (Investments) make?
Answered in the full report
›Is Smithkline Beecham (Investments) profitable?
Smithkline Beecham (Investments)'s profit isn't public: small companies may file without a profit and loss account.
›Who runs and owns Smithkline Beecham (Investments)?
Its directors are Edinburgh Pharmaceutical Industries Limited, Laura Guittard, Edinburgh Pharmaceutical Industries Limited, Glaxo Group Limited. Its owners are shown to subscribers.
›Where is Smithkline Beecham (Investments) based?
Its registered office is 79 New Oxford Street, London, WC1A 1DG, in London.
›When was Smithkline Beecham (Investments) founded?
Smithkline Beecham (Investments) Limited was incorporated on 21 June 1935.
›Is Smithkline Beecham (Investments) still trading?
The register lists Smithkline Beecham (Investments) Limited as active.